2021
DOI: 10.1002/clc.23669
|View full text |Cite
|
Sign up to set email alerts
|

Does continuous positive airway pressure therapy benefit patients with coronary artery disease and obstructive sleep apnea? A systematic review and meta‐analysis

Abstract: The prevalent co‐morbidity of coronary artery disease (CAD) and obstructive sleep apnea (OSA) has attracted great interest. However, effects of continuous positive airway pressure (CPAP) in patients with OSA and CAD for cardiovascular outcomes and deaths are still controversial. Usage of CPAP among patients with CAD and OSA could decrease the risk of cardiovascular events and death in adults. PubMed, EMBASE, Web of science, and Cochrane Library were systematically searched. Studies that described association o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 47 publications
(123 reference statements)
0
4
0
Order By: Relevance
“…Continuous Positive Airway Pressure (CPAP) is the treatment of choice for moderate to severe OSAS (Zhang et al, 2015;Chen et al, 2021;Sugiyama et al, 2021). It involves the use of an airflow generator which provides a constant stream of pressurized air to splint open and maintain patency of the upper airways during the inspiratory and expiratory phases of breathing.…”
Section: Introductionmentioning
confidence: 99%
“…Continuous Positive Airway Pressure (CPAP) is the treatment of choice for moderate to severe OSAS (Zhang et al, 2015;Chen et al, 2021;Sugiyama et al, 2021). It involves the use of an airflow generator which provides a constant stream of pressurized air to splint open and maintain patency of the upper airways during the inspiratory and expiratory phases of breathing.…”
Section: Introductionmentioning
confidence: 99%
“…OSA induces a proinflammatory state in our body, as evidenced by increased C-reactive protein levels. 19 In a study conducted by Zhong et al, 20 it was found that patients with OSA and hypopnea syndrome have impaired baseline endothelial function and autonomic modulation compared to their non OSAHS counterparts. Vascular cell adhesion factor 1 (VCAM-1) levels were significantly elevated in patients with moderate and severe OSA, and elevated VCAM-1 was positively associated with the severity of CAD in moderate to severe OSA patients.…”
Section: Central Sleep Apneamentioning
confidence: 99%
“…OSA may overactivate the sympathetic nervous system promoting release of vasoconstrictor like catecholamines, angiotensin II, causing an increase in night blood pressure and heart rate, and may result in increasing myocardial oxygen demand and cardiac load leading to a cardiovascular event. 19 OSA may be responsible for an increased risk of major adverse cardiovascular event even after percutaneous coronary intervention (PCI). 23 The mechanism of how CSA impacts overall cardiovascular health is similar to OSA.…”
Section: Central Sleep Apneamentioning
confidence: 99%
See 1 more Smart Citation
“…This article examines the relationship between OSA and cardiovascular risk in addition to reviewing recent clinical studies, systematic reviews, and meta-analyses on the effectiveness of CPAP in primary and secondary cardiovascular prevention. Type II diabetes mellitus and OSA usually coexist together as per estimates from clinics, type II diabetics with OSA have a prevalence of 18% to 36% [ 1 - 3 ], and 50% of OSA patients also have type II diabetes or impaired glucose metabolism [ 9 ]. Early CPAP therapy improves long-term survival in individuals with ischemic stroke with moderate-severe OSA [ 10 ].…”
Section: Introductionmentioning
confidence: 99%